HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

TUCSON, Ariz., Sept. 21, 2021 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will present in a fireside chat in Cantor Fitzgerald’s Virtual Global Healthcare Conference, being held September 27^th – 30^th, 2021.

Details for the fireside chat are below:

Management will also be available for 1×1 meetings. If you would like to request a meeting, please email corporateaccess@cantor.com

About HTG:
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptnome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.

Contact:

Ashley Robinson
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com